Purchase Order 75D30121P10600
- Not listed
- This $400,185.00 definitive contract was awarded by the Centers for Disease Control and Prevention (CDC) to the Georgia Tech Research Corporation (Georgia Tech) to support COVID-19 research under the FY 2020 Broad Agency Announcement (BAA) Topic 1. The contract has a period of performance ending on June 30, 2022 and does not have a set-aside designation. As a non-profit research organization and state institution of higher learning, Georgia Tech has extensive experience conducting research and...
- This is a $300,000.00 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the Georgia Tech Research Corporation for mathematical modeling services. The contract has no set-aside designation. As a prime contractor, Georgia Tech Research Corporation, which is a non-profit research organization and state institution of higher education, will provide the services. Two key subcontractors are Duke University and Asrt, Inc., a small disadvantaged...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $599,899.12 definitive contract to the Georgia Tech Research Corporation (Georgia Tech) to support COVID-19 research under the FY 2020 COVID-19 Broad Agency Announcement (BAA) Topic 3.1. The contract, which does not have a set-aside designation, is for a project titled "FY 2020 COVID-19 BAA TOPIC 3.1 GA TECH" with a period of performance through September 29, 2022. As a non-profit research organization and state...
- This is a $345,000.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the Georgia Tech Research Corporation, also known as the Office of Sponsored Programs. The contract is for FY 2020 COVID-19 Broad Agency Announcement (BAA) Topic 1 research and was awarded on March 15, 2021, with a completion date of June 30, 2023. Georgia Tech Research Corporation is a non-profit research organization and state institution of higher education associated with the...
- This is a $274,822.00 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the Georgia Tech Research Corporation, also known as the Office of Sponsored Programs, on July 1, 2021. The contract supports FY 2020 COVID-19 Broad Agency Announcement (BAA) Topic 2 and has an ultimate completion date of April 29, 2022. Georgia Tech Research Corporation is a non-profit research organization and state institution of higher education associated with the...
- The Centers for Disease Control and Prevention (CDC) Atlanta awarded a $145.8K firm fixed-price purchase order to Georgia Tech Research Corporation to characterize pathogen-specific antibody responses related to COVID-19. The award, issued on August 25, 2021, carries an ultimate completion date of August 31, 2025, with performance taking place in Atlanta, Georgia. No set-aside designation was applied to this contract, indicating open competition. Georgia Tech Research Corporation, operating...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to the Georgia Tech Research Corporation, a non-profit organization and state-controlled institution of higher education. The $133,000 contract is for the development of monoclonal antibodies and immunoassays to spike variants, in support of the national response to the Coronavirus (COVID-19) pandemic. Georgia Tech Research Corporation has extensive...
- The Centers for Disease Control and Prevention awarded a $94,061 firm fixed price purchase order to the Georgia Tech Research Corporation, doing business as the Office of Sponsored Programs, for molecular dynamics modeling services. The contract has a period of performance from September 2023 through September 2026. The work will be conducted at the prime contractor's location in Chamblee, Georgia and supports the CDC's disease prevention programs through computational modeling and simulation....
- This is a definitive contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Georgia Institute of Technology Research Corporation (Georgia Tech Research Corp), doing business as the Office of Sponsored Programs. The contract, awarded on September 22, 2017, has a potential value of $301,682.00 and a completion date of March 31, 2019. The contract is not designated as a set-aside. Georgia Tech Research Corp is a non-profit...
- This is a $150,000 firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Georgia Tech Research Corporation, doing business as the Office of Sponsored Programs. The contract is for technical services and does not have a set-aside designation. Georgia Tech Research Corporation is a non-profit research organization and state institution of higher education that provides a range of research,...
This firm fixed price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Georgia Tech Research Corporation (Georgia Tech) for $300,000.00 to provide mathematical modeling in support of the COVID-19 response. The contract period of performance is from May 10, 2021 to April 25, 2022. This award does not have a small business set-aside designation. Georgia Tech, a non-profit research organization and state institution of higher education, has a history of providing research, engineering, software development, testing, analysis, modeling, simulation, and other technical and scientific services to federal agencies through prime and subcontracts, including work for the Department of the Air Force and the National Science Foundation. The CDC contract leverages Georgia Tech's expertise in areas like materials science, physics, engineering, and public health to support the agency's modeling needs related to the COVID-19 pandemic.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $300.0k | 5/10/21 |